Horizon Therapeutics M&A Summary
Horizon Therapeutics has acquired 12 companies of its own, including 3 in the last 5 years. A total of 4 acquisitions came from private equity firms. It has also divested 1 asset.
Horizon Therapeutics’ largest acquisition to date was in 2021, when it acquired Viela Bio for $3.1B. It’s largest disclosed sale occurred in 2017, when it sold Raptor Pharmaceuticals to Chiesi Farmaceutici for $70M. Horizon Therapeutics has acquired in 6 different US states, and 3 countries. The Company’s most targeted sectors include life science (100%).
M&A Summary
-
M&A Total Activity12
- M&A Buy Activity11
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 3
- M&A Buy/Sell Connections 9